Pharmaceutical Regulatory Affairs: Open Access

Department of Preclinical Research, University of Pennsylvania, Philadelphia, USA

Publications

• Mini Review   
  The Role of AI in Accelerating New Molecular Entity Discovery
  Author(s): Damjanovic Tamposis*
  
  The field of drug discovery has been revolutionized by the integration of Artificial Intelligence (AI) into the research and development process. This article explores the pivotal role AI plays in accelerating the discovery of New Molecular Entities (NMEs) and improving the efficiency of drug development. We delve into the various ways AI is being applied in drug discovery, from target identification and lead compound optimization to clinical trial design. By harnessing the power of AI, the pharmaceutical industry is on the cusp of a new era, one where the development of lifesaving medications is faster, more cost-effective and ultimately, more successful... Read More»
  DOI: 10.37421/2167-7689.2023.12.371

  Abstract HTML PDF